OBIO

5.08

7.17% 0.34

Handel nachbörslich: 5.08

Orchestra Biomed Holdings Inc (OBIO)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$4.74

Offen:

$4.71

24-Stunden-Volumen:

478.14K

Relative Volume:

1.42

Marktkapitalisierung:

$305.33M

Einnahmen:

$32.72M

Nettoeinkommen (Verlust:

$-54.64M

KGV:

-4.5047

EPS:

-1.1277

Netto-Cashflow:

$-55.08M

1W Leistung:

-2.03%

1M Leistung:

+18.97%

6M Leistung:

+11.40%

1J Leistung:

+85.40%

1-Tages-Spanne:

$4.71

$5.14

1-Wochen-Bereich:

$4.71

$5.3492

52-Wochen-Spanne:

$2.20

$5.78

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Firmenname

Orchestra Biomed Holdings Inc

Sektor

Healthcare (1074)

Branche

Biotechnology (600)

Telefon

646-343-9298

Adresse

150 UNION SQUARE DRIVE, NEW HOPE

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-11

Neueste SEC-Einreichungen

OBIO's Discussions on Twitter

Compare OBIO vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OBIO Orchestra Biomed Holdings Inc	5.08	326.37M	32.72M	-54.64M	-55.08M	-1.1277
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-10	Eingeleitet	TD Cowen	Buy
2025-08-20	Herabstufung	BTIG Research	Buy → Neutral
2025-03-20	Eingeleitet	BTIG Research	Buy
2025-01-02	Eingeleitet	Barclays	Overweight
2024-08-22	Eingeleitet	H.C. Wainwright	Buy
2024-07-25	Eingeleitet	B. Riley Securities	Buy
2024-01-19	Eingeleitet	Jefferies	Buy
2023-02-24	Eingeleitet	Piper Sandler	Overweight
2023-02-07	Eingeleitet	Chardan Capital Markets	Buy

Alle ansehen

Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten

Aug 20, 2026

Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire

Aug 20, 2026

Aug 19, 2026

Insiders Buying Orchestra BioMed Holdings Might Wish They Invested More, Stock Gains 29% - Moomoo

Aug 19, 2026

Orchestra (OBIO) Q2 2026 Results: Profit Per Share Clears Its Benchmark for the Current Session; Investor Response: Shares Finish 19.92% Higher in Latest TradingInvestor Earnings Call - vinanet.vn

Aug 19, 2026

Aug 18, 2026

Orchestra (OBIO) Reported Results Review: EPS Prints Above Forecast for the Current Session; Price Action: Shares Close 19.92% Higher at the CloseProfit Recovery Report - vinanet.vn

Aug 18, 2026

Orchestra BioMed Loss Widens as Pivotal Trials Advance - MyChesCo

Aug 18, 2026

Aug 16, 2026

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Aug 16, 2026

Aug 14, 2026

Orchestra BioMed (OBIO) director withholds 3,761 shares to cover RSU tax bill - Stock Titan

Aug 14, 2026

Orchestra BioMed (OBIO) director uses 5,145 shares to cover RSU tax withholding - Stock Titan

Aug 14, 2026

Orchestra BioMed (OBIO) director has 4,885 shares withheld for RSU tax - Stock Titan

Aug 14, 2026

Orchestra BioMed (OBIO) director reports 4,238 RSU tax-withholding shares - Stock Titan

Aug 14, 2026

Orchestra BioMed (OBIO) Holds Gains at $4.45, Consolidating Between Key Technical LevelsComposite Profile - vinanet.vn

Aug 14, 2026

Research Analysts Offer Predictions for OBIO Q3 Earnings - MarketBeat

Aug 14, 2026

Aug 13, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - theglobeandmail.com

Aug 13, 2026

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st

Aug 13, 2026

Aug 11, 2026

Piper Sandler Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Raises Target Price to $10 - Moomoo

Aug 11, 2026

Orchestra BioMed Holdings, Inc. Stock 12‑Month Price Target Raised to $12.33, Implies 177% Upside - TradingView

Aug 11, 2026

Orchestra Biomed Holdings earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada

Aug 11, 2026

Aug 10, 2026

Orchestra Biomed Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 10, 2026

Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - Investing News Network

Aug 10, 2026

OBIO Looks 87.4% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus

Aug 10, 2026

Orchestra BioMed reports $24.1M Q2 loss, secures $35M capital - scanx.trade

Aug 10, 2026